Key Takeaways:The acquisition represents a significant strategic milestone for Newmedical, bringing a highly complementary professional skincare brand into its portfolio.Derma Made’s US presence and national distribution complement Newmedical’s professional channel strength.This acquisition significantly broadens its portfolio, spanning clinical recovery, post-procedure care, aesthetic skin health, and everyday skincare.The strategic addition of Derma Made strengthens Newmedical’s professional and consumer divisions worldwide and accelerates international growth opportunities.WHO: Derma Made was launched in 2021 by Dr. Amy Brodsky, a dermatologist and biomedical engineer, to develop and provide affordable, prescription-effective skincare. The products use evidence-based ingredients and formulations to address specific skin concerns, such as dryness and irritation, acne, aging, dark spots, and rosacea. The brand has national reach, focused on delivering outstanding value for patients across its categories and supporting the evolving needs of medical and aesthetic dermatology and medspa customers.Newmedical Technology, headquartered in Northbrook, Illinois, is a global, US-based medical device manufacturer and skin-health company specializing in clinically proven solutions for scar management, wound care, post-procedure recovery, and aesthetic medicine. The company designs, manufactures, and commercializes innovative products trusted by physicians, hospitals, dermatology clinics, plastic surgeons, and medspas in over 50 countries worldwide.